Shenzhen Bioeasy (China) Performance
| 300942 Stock | 9.92 0.15 1.49% |
On a scale of 0 to 100, Shenzhen Bioeasy holds a performance score of 12. The entity has a beta of 0.62, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Shenzhen Bioeasy's returns are expected to increase less than the market. However, during the bear market, the loss of holding Shenzhen Bioeasy is expected to be smaller as well. Please check Shenzhen Bioeasy's market risk adjusted performance, semi deviation, coefficient of variation, as well as the relationship between the mean deviation and downside deviation , to make a quick decision on whether Shenzhen Bioeasy's existing price patterns will revert.
Risk-Adjusted Performance
12 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Shenzhen Bioeasy Biotechnology are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shenzhen Bioeasy sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Ex Dividend Date 2023-05-31 |
1 | Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 - Marketscreener.com | 11/21/2024 |
| Begin Period Cash Flow | 247.2 M |
Shenzhen |
Shenzhen Bioeasy Relative Risk vs. Return Landscape
If you would invest 665.00 in Shenzhen Bioeasy Biotechnology on September 5, 2024 and sell it today you would earn a total of 327.00 from holding Shenzhen Bioeasy Biotechnology or generate 49.17% return on investment over 90 days. Shenzhen Bioeasy Biotechnology is generating 0.8089% of daily returns and assumes 4.9665% volatility on return distribution over the 90 days horizon. Simply put, 44% of stocks are less volatile than Shenzhen, and 84% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Shenzhen Bioeasy Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shenzhen Bioeasy's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Shenzhen Bioeasy Biotechnology, and traders can use it to determine the average amount a Shenzhen Bioeasy's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1629
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 300942 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.97 actual daily | 44 56% of assets are more volatile |
Expected Return
| 0.81 actual daily | 16 84% of assets have higher returns |
Risk-Adjusted Return
| 0.16 actual daily | 12 88% of assets perform better |
Based on monthly moving average Shenzhen Bioeasy is performing at about 12% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Shenzhen Bioeasy by adding it to a well-diversified portfolio.
Shenzhen Bioeasy Fundamentals Growth
Shenzhen Stock prices reflect investors' perceptions of the future prospects and financial health of Shenzhen Bioeasy, and Shenzhen Bioeasy fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Shenzhen Stock performance.
| Return On Equity | -0.0919 | ||||
| Return On Asset | -0.0157 | ||||
| Profit Margin | (0.33) % | ||||
| Operating Margin | 0.02 % | ||||
| Current Valuation | 3.86 B | ||||
| Shares Outstanding | 400.87 M | ||||
| Price To Book | 4.66 X | ||||
| Price To Sales | 15.54 X | ||||
| Revenue | 254.11 M | ||||
| Gross Profit | 428.03 M | ||||
| EBITDA | (16.9 M) | ||||
| Net Income | (184.91 M) | ||||
| Total Debt | 507.61 M | ||||
| Book Value Per Share | 2.13 X | ||||
| Cash Flow From Operations | (37.25 M) | ||||
| Earnings Per Share | (0.20) X | ||||
| Total Asset | 1.36 B | ||||
| Retained Earnings | 138.44 M | ||||
About Shenzhen Bioeasy Performance
By analyzing Shenzhen Bioeasy's fundamental ratios, stakeholders can gain valuable insights into Shenzhen Bioeasy's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Shenzhen Bioeasy has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Shenzhen Bioeasy has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Shenzhen Bioeasy is entity of China. It is traded as Stock on SHE exchange.Things to note about Shenzhen Bioeasy Bio performance evaluation
Checking the ongoing alerts about Shenzhen Bioeasy for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Shenzhen Bioeasy Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Shenzhen Bioeasy Bio appears to be risky and price may revert if volatility continues | |
| The company reported the revenue of 254.11 M. Net Loss for the year was (184.91 M) with profit before overhead, payroll, taxes, and interest of 428.03 M. | |
| Shenzhen Bioeasy generates negative cash flow from operations | |
| About 75.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Shenzhen Bioeasy Biotechnology Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 - Marketscreener.com |
- Analyzing Shenzhen Bioeasy's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Shenzhen Bioeasy's stock is overvalued or undervalued compared to its peers.
- Examining Shenzhen Bioeasy's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Shenzhen Bioeasy's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Shenzhen Bioeasy's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Shenzhen Bioeasy's stock. These opinions can provide insight into Shenzhen Bioeasy's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Shenzhen Stock analysis
When running Shenzhen Bioeasy's price analysis, check to measure Shenzhen Bioeasy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shenzhen Bioeasy is operating at the current time. Most of Shenzhen Bioeasy's value examination focuses on studying past and present price action to predict the probability of Shenzhen Bioeasy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shenzhen Bioeasy's price. Additionally, you may evaluate how the addition of Shenzhen Bioeasy to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |